Get started
Author

Viktoriia Starokozhko

Observed names: Starokozhko, Viktoriia, V. Starokozhko
ORCID: 0000-0002-7451-6793
Observed ORCID: 0000-0002-7451-6793
OpenAlex ID: A5010673228
Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
2022 · Elisabeth Bakker, Kelly Plueschke, et al. · Clinical Pharmacology & Therapeutics · 81
PDF
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020
2022 · Elisabeth Bakker, Natalie M. Hendrikse, et al. · Clinical Pharmacology & Therapeutics · 64
Human Precision-Cut Liver Slices as anex VivoModel to Study Idiosyncratic Drug-Induced Liver Injury
2013 · Mackenzie Hadi, Inge M. Westra, et al. · Chemical Research in Toxicology · 55
Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap
2020 · Viktoriia Starokozhko, Marko Kallio, et al. · Drug Discovery Today · 42
PDF
Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days
2016 · Viktoriia Starokozhko, Suresh Vatakuti, et al. · Archives of Toxicology · 37
PDF
Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium
2015 · Viktoriia Starokozhko, Getahun B. Abza, et al. · Toxicology in Vitro · 37
PDF
Judging the value of ‘liver-on-a-chip’ devices for prediction of toxicity
2016 · Viktoriia Starokozhko, Geny M. M. Groothuis · Expert Opinion on Drug Metabolism & Toxicology · 32
PDF
Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering
2018 · Viktoriia Starokozhko, Mette Hemmingsen, et al. · Journal of Tissue Engineering and Regenerative Medicine · 30
PDF
Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020
2023 · Elisabeth Bakker, Viktoriia Starokozhko, et al. · Clinical and Translational Science · 22
PDF
Mouse Precision-Cut Liver Slices as an ex Vivo Model To Study Idiosyncratic Drug-Induced Liver Injury
2012 · Mackenzie Hadi, Yixi Chen, et al. · Chemical Research in Toxicology · 22
Rat precision-cut liver slices predict drug-induced cholestatic injury
2017 · Viktoriia Starokozhko, Rick Greupink, et al. · Archives of Toxicology · 20
PDF
Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe
2022 · Marko J. Kallio, Viktoriia Starokozhko, et al. · Clinical Pharmacology & Therapeutics · 18
PDF
Challenges on the road to a multicellular bioartificial liver
2016 · Viktoriia Starokozhko, Geny M.M. Groothuis · Journal of Tissue Engineering and Regenerative Medicine · 18
PDF
Strategic recommendations from the STARS project to foster academic drug development
2023 · Viktoriia Starokozhko, Anne Heß, et al. · Nature Reviews Drug Discovery · 11
Attention for sex in COVID-19 trials: a review of regulatory dossiers
2022 · Sieta T de Vries, Viktoriia Starokozhko, et al. · BMJ Global Health · 8
PDF
Disruption of vitamin A homeostasis by the biocide tetrakis(hydroxymethyl) phosphonium sulphate in pregnant rabbits
2022 · Natalia Estrada‐Ortiz, Viktoriia Starokozhko, et al. · Journal of Applied Toxicology · 4
PDF
Biomarkers for neurodegenerative diseases in regulatory decision‐making by the European Medicines Agency
2025 · Audrey M. M. Hermans, Elisabeth Bakker, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 3
PDF
How microtechnologies enable organs-on-a-chip
2015 · E. Verpoorte, P.E. Oomen, et al. · International Conference on Solid-State Sensors, Actuators and Microsystems · 3
The European Innovation Network as a hub for medicines innovation in Europe
2024 · Eleonora Agricola, Caroline Auriche-Benichou, et al. · Nature Reviews Drug Discovery · 2
Safety‐Related Drug Label Changes Following Large Post‐Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports
2023 · Viktoriia Starokozhko, Fatima Tarrahi, et al. · Clinical Pharmacology & Therapeutics · 2
PDF
Erratum to: Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days
2016 · Viktoriia Starokozhko, Suresh Vatakuti, et al. · Archives of Toxicology · 1
PDF
More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations
2026 · Renske Johanna Grupstra, Viktoriia Starokozhko, et al. · Clinical Pharmacology & Therapeutics
PDF
3D liver models in tissue engineering and toxicology
2016 · Starokozhko, Viktoriia · University of Groningen research database (University of Groningen / Centre for Information Technology)
PCLS as a model to study drug-induced cholestasis
2015 · Soliman, Nashwa, Starokozhko, Viktoriia, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
Species-specific effects of incubation media on precision-cut liver slices cultured in vitro
2015 · Starokozhko, Viktoriia, Groothuis, Genoveva · University of Groningen research database (University of Groningen / Centre for Information Technology)
Works count: 27
Citation count: 512
H-index: 13
I10-index: 14
Year
Topic
Type